Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/FAB stock hub

AIM/FAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/FABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.9M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/FAB

In the news

Latest news · AIM/FAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-164.4

P25 -54.2P50 2.1P75 13.7

ROIC-170.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/FAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

GBP

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	24
Employees Change	-3%
Employees Change Percent	-11.11
Enterprise value	GBX 17M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BDQZGK16
Last refreshed	2026-05-10
Market cap	GBX 16.9M
Price	GBX 13.5
Price currency	GBX
Rev Per Employee	66,500x
Sector	Healthcare
Sic	8731
Symbol	aim/FAB
Website	https://www.fusionantibodies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.69%
EV Earnings	-11.6x
EV/FCF	-13.62x
EV/Sales	10.66x
FCF yield	-7.4%
P/B ratio	23.25x
P/S ratio	10.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-92.23%
EBITDA Margin	-87.59%
Gross margin	22.06%
Gross Profit	GBX 352,000
Gross Profit Growth	-18.14%
Gross Profit Growth Q	-24%
Gross Profit Growth5 Y	-9.32%
Net Income	GBX -1.5M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-96.05%
Profit Margin	-91.92%
Profit Per Employee	GBX -61,125
ROA	-55.09
Roa5y	-40.28
ROCE	-141.5
ROE	-164.4
Roe5y	-97.79
ROIC	-170.8
Roic5y	-191.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	132.89%
Cagr3y	-30.37%
Cagr5y	-38.22%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth	-11.43x
Revenue Growth Q	-30.57x
Revenue Growth Years	1x
Revenue Growth3 Y	12x
Revenue Growth5 Y	-11.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.96
Assets	GBX 1.8M
Cash	GBX 252,000
Current Assets	GBX 1.4M
Current Liabilities	GBX 772,000
Debt	GBX 388,000
Debt Equity	GBX 0.53
Debt FCF	GBX -0.31
Equity	GBX 726,000
Interest Coverage	-133.8
Liabilities	GBX 1.1M
Long Term Assets	GBX 420,000
Long Term Liabilities	GBX 314,000
Net Cash	GBX -136,000
Net Cash By Market Cap	GBX -0.81
Net Debt Equity	GBX 0.19
Tangible Book Value	GBX 726,000
Tangible Book Value Per Share	GBX 0.01
WACC	10.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.8
Inventory Turnover	4.96
Net Working Capital	GBX 473,000
Quick ratio	1.45
Working Capital	GBX 620,000
Working Capital Turnover	GBX 1.98

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-31.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	132.76%
200-day SMA	14.05
3Y total return	-66.25%
50-day SMA	13.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-91%
All Time High	250
All Time High Change	-94.6%
All Time High Date	2020-09-18
All Time Low	2.8
All Time Low Change	382.14%
All Time Low Date	2024-07-10
ATR	1.28
Beta	1.2
Beta1y	0.79
Beta2y	0.65
Ch YTD	-3.57
High	13.5
High52	21
High52 Date	2025-09-24
High52ch	-35.71%
Low	12.67
Low52	5.6
Low52 Date	2025-05-09
Low52ch	141.07%
Ma50ch	1.63%
Price vs 200-day SMA	-3.94%
RSI	49.97
RSI Monthly	48.23
RSI Weekly	49.72
Sharpe ratio	1.4x
Sortino ratio	2.63
Total Return	-31.3%
Tr YTD	-3.57
Tr1m	3.85%
Tr1w	-3.57%
Tr3m	-15.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -1.5M
Operating margin	-92.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,106,911%
Net Borrowing	-52,000
Shares Insiders	4.19%
Shares Institutions	77.1%
Shares Out	125,021,878
Shares Qo Q	17.91%
Shares Yo Y	31.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -1.3M
Average Volume	519,276.8x
Bv Per Share	0.01
CAPEX	GBX -70,000
Ch1m	3.85
Ch1w	-3.57
Ch1y	132.8
Ch3m	-15.63
Ch3y	-66.25
Ch5y	-91
Ch6m	3.85
Change	3.85%
Change From Open	6.55
Close	13
Days Gap	-2.54
Depreciation Amortization	74,000
Dollar Volume	4,999,671
Earnings Date	2026-09-07
EBIT	GBX -1.5M
EBITDA	GBX -1.4M
EPS	GBX -0.01
F Score	2
FCF	GBX -1.2M
FCF EV Yield	-7.34x
FCF Per Share	GBX -0.01
Financing CF	1,060,000
Fiscal Year End	March
Founded	2,000
Income Tax	GBX -66,000
Investing CF	-67,000
Is Primary Listing	1
Last Earnings Date	2026-02-24
Last Report Date	2025-09-30
Ma150	13.82
Ma150ch	-2.34%
Ma20	13.81
Ma20ch	-2.27%
Net CF	-187,000
Next Earnings Date	2026-09-07
Open	12.67
Position In Range	100
Ppne	420,000
Price Date	2026-05-08
Ptbv Ratio	23.25
Relative Volume	0.7x
Revenue	1,596,000x
SBC By Revenue	0.69x
Share Based Comp	11,000
Tax By Revenue	-4.14x
Tr6m	3.85%
Volume	370,346
Z Score	-5.92

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/FAB pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/FAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/FAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.1%

Share of float held by funds and institutions

Insider ownership

+4.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+31.3%

Negative means the company is buying back shares.

Technical

AIM/FAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.0

Neutral momentum band

Price vs 200-day MA

-3.9%

50/200-day relationship not available

Beta (5Y)

1.20

Moves roughly with the market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/FAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/FAB stock rating?

aim/FAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/FAB analysis?

The full report lives at /stocks/aim/FAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/FAB?

The latest report frames aim/FAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/FAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.